Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Apr
3
2021
Guangdong Higher People’s Court Ups Damages 10X on Appeal in Trademark Infringement Case for Lego Bricks Schwegman, Lundberg & Woessner, P.A.
Apr
27
2021
Guest Post: Well-Know Mark Recognitions in China – Part IV Schwegman, Lundberg & Woessner, P.A.
Dec
19
2014
Cooler Heads Prevail in New Interim Guidance on Patent Subject Matter Eligibility Schwegman, Lundberg & Woessner, P.A.
May
31
2021
Per CNIPA, 43% of Chinese Patent Firms Have Submitted ‘Irregular’ Patent Applications Schwegman, Lundberg & Woessner, P.A.
Jul
19
2017
Millennium Pharm. v. Sandoz, Inc. – Revenge of the Chemical Judges Schwegman, Lundberg & Woessner, P.A.
Mar
11
2015
Takeaways from Chisum Patent Academy 2015 Seminar in Cincinnati Schwegman, Lundberg & Woessner, P.A.
Oct
16
2021
CareDx v. Natera – Are Processing Steps Known to the Art Always “Conventional”? Schwegman, Lundberg & Woessner, P.A.
Mar
19
2015
Enzo Biochem V. Applera Corp. – When “Words Can Hurt You” Schwegman, Lundberg & Woessner, P.A.
Oct
31
2021
China Sentences Shoe Polish Counterfeiters to Up To 3 Years in Prison in Criminal Trademark Case Schwegman, Lundberg & Woessner, P.A.
Apr
2
2011
One Step Towards an EJC Decision on the Patentability of Embryonic Stem Cells in Europe Schwegman, Lundberg & Woessner, P.A.
Apr
13
2011
Fixing The Holes – Proposed Patent Reform Bill Amendment De-Bugs Grace Period Schwegman, Lundberg & Woessner, P.A.
Feb
2
2022
China’s National Intellectual Property Administration Releases 2021 Results for the Blue Sky IP Agency Rectification Campaign Schwegman, Lundberg & Woessner, P.A.
May
6
2011
Oracle Ordered to Reduce the Number of Patent Infringement Claims against Google Schwegman, Lundberg & Woessner, P.A.
Jun
23
2011
Supreme Court Grants Cert. In Mayo v. Prometheus Schwegman, Lundberg & Woessner, P.A.
Jun
8
2022
China’s National Intellectual Property Administration Announces Record 2.49 Million RMB Fine Against Patent Firm for Unauthorized Practice of Law and Filing Abnormal Patent Applications Schwegman, Lundberg & Woessner, P.A.
Feb
28
2012
Bayer v. Lupin – Patenting The Label Redux Schwegman, Lundberg & Woessner, P.A.
Jul
28
2022
Even the Chinese Government isn’t Safe from Counterfeiters: China Cracks Down on Counterfeit Mail Trucks Schwegman, Lundberg & Woessner, P.A.
Jul
9
2015
Intellectual Ventures I v. Capitol One Bank: Mental Steps Doctrine Making Strong Comeback, Courtesy of Alice Schwegman, Lundberg & Woessner, P.A.
Mar
29
2012
Legal Challenge To “ObamaCare” Threatens Generic Biologicals Schwegman, Lundberg & Woessner, P.A.
Aug
24
2022
20,000 RMB for Passing Chinese Patent Bar in Guangzhou Schwegman, Lundberg & Woessner, P.A.
Aug
29
2022
Supreme People’s Court Upholds China’s First Patent Linkage Ruling – Decision Released Schwegman, Lundberg & Woessner, P.A.
May
24
2012
Prometheus Unbound – Are Methods Of Medical Treatment The Next “Targets”? Schwegman, Lundberg & Woessner, P.A.
Jun
28
2012
“Obamacare” Survives – Including Path to Generic Biologicals Schwegman, Lundberg & Woessner, P.A.
Jul
11
2012
“In Leukemia Treatment, Glimpses of the Future” of Medicine and IP Schwegman, Lundberg & Woessner, P.A.
Dec
17
2022
Mast-Jägermeister SE Wins 10 Million RMB at Beijing IP Court for Trademark Infringement and Unfair Competition Schwegman, Lundberg & Woessner, P.A.
Sep
3
2015
Another Claim Bites the Dust left by Teva v. Sandoz Schwegman, Lundberg & Woessner, P.A.
Nov
16
2012
Bard v. Gore: Joint Inventors or Just One? Schwegman, Lundberg & Woessner, P.A.
Apr
6
2023
China’s Supreme People’s Court Releases “Summary of Judgments of the Intellectual Property Tribunal of the Supreme People’s Court (2022)” Schwegman, Lundberg & Woessner, P.A.
Jan
20
2013
USPTO Publishes Final Rules for Micro-Entity Status and Fee Schedule Schwegman, Lundberg & Woessner, P.A.
Sep
24
2018
“Big Data” Claims Meet Mayo/Alice Rule Schwegman, Lundberg & Woessner, P.A.
Feb
22
2013
Is Software Different than other Technologies? Yes and No Schwegman, Lundberg & Woessner, P.A.
Apr
9
2013
NOVARTIS A.G. v. UOI – What is Novelty in Indian Courts? Schwegman, Lundberg & Woessner, P.A.
Apr
25
2013
Patent Trial and Appeal Board Inter Partes Review (IPR) Petition Joinder Practice Gains Momentum Schwegman, Lundberg & Woessner, P.A.
Mar
18
2019
Split Federal Circuit Panel Holds That Method of Medical Treatment Claims are Patent Eligible Schwegman, Lundberg & Woessner, P.A.
Oct
7
2023
The Tyranny of Large Numbers: Their Grip on s. 102 Inquiries Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins